Identification of the sites of tau hyperphosphorylation and activation of tau kinases in synucleinopathies and Alzheimer's diseases.
about
Phosphatases of α-synuclein, LRRK2, and tau: important players in the phosphorylation-dependent pathology of ParkinsonismPathogenesis of synaptic degeneration in Alzheimer's disease and Lewy body diseaseGSK-3β dysregulation contributes to parkinson's-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and α-synucleinGSK-3β-induced Tau pathology drives hippocampal neuronal cell death in Huntington's disease: involvement of astrocyte-neuron interactionsProtein phosphorylation in neurodegeneration: friend or foe?Molecular changes in the postmortem parkinsonian brain.Regulatory region genetic variation is associated with FYN expression in Alzheimer's disease.FLEXITau: Quantifying Post-translational Modifications of Tau Protein in Vitro and in Human Disease.Presence of tau pathology within foetal neural allografts in patients with Huntington's and Parkinson's disease.ReMAPping the microtubule landscape: How phosphorylation dictates the activities of microtubule-associated proteins.Protein Phosphatase 2A and Its Methylation Modulating Enzymes LCMT-1 and PME-1 Are Dysregulated in Tauopathies of Progressive Supranuclear Palsy and Alzheimer Disease.HS3ST2 expression is critical for the abnormal phosphorylation of tau in Alzheimer's disease-related tau pathology.Atorvastatin ameliorates cognitive impairment, Aβ1-42 production and Tau hyperphosphorylation in APP/PS1 transgenic mice.Tau Pathology in Parkinson's Disease
P2860
Q21131229-7458F1FD-936E-488A-975F-A9F99120D860Q26853610-1526B11E-9756-4711-A099-643D9F19BC4CQ27331743-74E71DAF-4433-48C7-8D10-42623DD1DF7EQ36002017-A02D352B-86B7-43F3-8E84-070090936868Q38214594-FDBB3B2D-BAE7-4B26-981A-FDC6EA030922Q38887346-80108C8F-7D31-40F2-AE34-A2F17B80B47DQ39052950-5EF1F366-11A1-4B14-91D3-EE1CDE1BAEC0Q41993280-379687EA-B850-4935-9CDE-56FDA22599FEQ45305113-E940000E-D434-4FD8-A9C2-A9F77907E86AQ46180253-6AEA6E72-F140-4742-8492-266FAFA422FEQ47252033-6035D2A2-8D66-48E8-A7E4-E4790D2CB2F1Q48246914-D19A08F1-F71E-4ECC-8911-FD59EAB5D9D0Q48901829-3E8065CF-5C96-4699-A967-2F13903AE481Q58586744-C698B58E-8600-4153-843F-FFD9A6FF88E0
P2860
Identification of the sites of tau hyperphosphorylation and activation of tau kinases in synucleinopathies and Alzheimer's diseases.
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Identification of the sites of ...... hies and Alzheimer's diseases.
@ast
Identification of the sites of ...... hies and Alzheimer's diseases.
@en
type
label
Identification of the sites of ...... hies and Alzheimer's diseases.
@ast
Identification of the sites of ...... hies and Alzheimer's diseases.
@en
prefLabel
Identification of the sites of ...... hies and Alzheimer's diseases.
@ast
Identification of the sites of ...... hies and Alzheimer's diseases.
@en
P2093
P2860
P1433
P1476
Identification of the sites of ...... hies and Alzheimer's diseases.
@en
P2093
Anita Sidhu
Ciaran Smolinsky
Deborah C Mash
Jae-Hoon Lee
Joel Credle
Jonathan Wills
Ketul Shah
Valeriy Duka
P2860
P304
P356
10.1371/JOURNAL.PONE.0075025
P407
P577
2013-09-20T00:00:00Z